GlaxoSmithKline and Vir submit Covid-19 mAb for emergency authorization

GlaxoSmithKline and Vir submit Covid-19 mAb for emergency authorization

Submitted by admin on March 26, 2021 - 10:45am
Source: 
Endpoints
News Tags: 
GSK
Vir Biotechnology
FDA
COVID-19
Emergency Use Authorization
monoclonal antibodies
Headline: 
GlaxoSmithKline and Vir submit Covid-19 mAb for emergency authorization
snippet: 

As the US continues to monitor the impact of variants on authorized monoclonal antibodies (mAbs) and shake up which mAbs are distributed where, GlaxoSmithKline and Vir Biotechnology said Friday that they’re seeking an emergency use authorization for their own mAb.

Do Not Allow Advertisers to Use My Personal information